US Stock MarketDetailed Quotes

HEPA Hepion Pharmaceuticals

Watchlist

0.8400
-0.1800-17.65%

Close Jul 22 16:00 ET

0.7901
-0.0499-5.94%

Post 19:33 ET

4.87MMarket Cap-89P/E (TTM)

Hepion Pharmaceuticals Stock Forum

103365182

10 hours ago

Trapped with Greed

$Hepion Pharmaceuticals(HEPA.US)$ Lost a bunch due to the pump & dump 📉 lesson learnt 😨

Trytosaveabit

11 hours ago

News

$Hepion Pharmaceuticals(HEPA.US)$ Pharma Two B Announces Plans to Go Public via Merger With Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement

Trytosaveabit

Apr 19 18:19

A shame especially with the study was going well! Wonder how much SS’s driving price so low ended up steering investors away? It happens sadly!

$Hepion Pharmaceuticals(HEPA.US)$ Hepion ends Phase 2 study for NASH drug due to cash restraints!
Hepion Pharmaceuticals (NASDAQ:HEPA) said it has begun winding down its ASCEND-NASH Phase 2 study for its drug rencofilstat as it continues to explore strategic alternatives for the company.
“We are disappointed to announce the wind-down of our Phase 2 NASHtr...

Stoic Trader

Feb 15 17:00

$Hepion Pharmaceuticals(HEPA.US)$ 👀break 3.50 we flying ✈️

Stoic Trader

Feb 15 15:54

$Hepion Pharmaceuticals(HEPA.US)$ 👀like downtrend is over for now prep for squeezing

Trytosaveabit

Dec 7, 2023 07:32

A bit more

$Hepion Pharmaceuticals(HEPA.US)$ Hepion Pharmaceuticals Expects Its Current Cash, Cash Equivalents and Investments Will Be Sufficient to Fund Its Ops Into Q2 2025

Trytosaveabit

Dec 7, 2023 07:11

$Hepion Pharmaceuticals(HEPA.US)$ Hepion Pharmaceuticals Announces Restructuring Plan To Enhance Shareholder Value And Management Changes; Reducing Operating Costs By ~60% Going Forward. Hepion Will Incur A One-Time Restructuring Charge Of ~$400K–$800K That Will Be Recorded In Q4 Of 2023

Trytosaveabit

Dec 7, 2023 07:10

Resume trade 8:30am est

$Hepion Pharmaceuticals(HEPA.US)$

Trytosaveabit

Dec 7, 2023 07:08

T1 News halt

$Hepion Pharmaceuticals(HEPA.US)$ watching closely

Trytosaveabit

Nov 28, 2023 06:35

Insider buy

$Hepion Pharmaceuticals(HEPA.US)$ Director Wijngaard Peter purchased 5,000 shares of Common Stocks on Nov 24, 27, 2023 at an average price of $3.07 for a total value of $15,350

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall